🇨🇦 ICS+LABA in Canada

ICS+LABA (ICS+LABA) regulatory status in Canada.

Marketing authorisation

ICS+LABA in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Other Other approved in Canada

Frequently asked questions

Is ICS+LABA approved in Canada?

Yes. Health Canada has authorised it.

Who is the marketing authorisation holder for ICS+LABA in Canada?

Shanghai Pulmonary Hospital, Shanghai, China is the originator. The local marketing authorisation holder may differ — check the official source linked above.